Fund Details
UTI Healthcare Fund Direct Growth
| Risk | Very High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 1.79% |
| NAV | ₹162.52 (20 Apr 2021) |
|---|---|
| Fund Started | 01 Jan 2013 |
| Fund Size | ₹618 Cr |
Returns
Comparison
1. 1Y Returns are higher than the category average returns
2. 5Y Returns are higher than the category average returns
1. Higher expense ratio - 1.79%
2. 3Y Returns are lower than the category average returns
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Aurobindo Pharma Ltd. | Healthcare | Equity | 9.6% |
| Cipla Ltd. | Healthcare | Equity | 9.5% |
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 9.5% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 8.4% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 6.2% |
| Eris Lifesciences Ltd | Healthcare | Equity | 5.7% |
| Cadila Healthcare Ltd. | Healthcare | Equity | 5.4% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 4.4% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 4.1% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 3.6% |
Fund Managers
UTI Healthcare Fund Direct Growth Details
UTI Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 01 Jan 2013. V Srivatsa, Ritesh Rathod is the Current Fund Manager of UTI Healthcare Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹618 Cr and the Latest NAV as of 20 Apr 2021 is ₹162.52.
The UTI Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 30 days.
Investment Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Tax Implications
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
